v3.25.1
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
AST Lease Amendment [Member]
Common Stock [Member]
AST Lease Amendment [Member]
Additional Paid-in Capital [Member]
AST Lease Amendment [Member]
Retained Earnings [Member]
AST Lease Amendment [Member]
Treasury Stock, Common [Member]
AST Lease Amendment [Member]
Noncontrolling Interest [Member]
AST Lease Amendment [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Treasury Stock, Common [Member]
Noncontrolling Interest [Member]
Total
BALANCE (in shares) at Dec. 31, 2023             11,786,208          
BALANCE at Dec. 31, 2023             $ 78,405 $ 363,889,245 $ (282,329,611) $ (3,360,867) $ 0 $ 78,277,172
Issuance of common stock (in shares)             410,270          
Issuance of common stock             $ 2,732 1,460,978 0 0 0 1,463,710
Common stock issuance costs             $ 0 (225,120) 0 0 0 (225,120)
Issuance of common stock for stock issuance costs (in shares)             25,000          
Issuance of common stock for stock issuance costs             $ 167 84,833 0 0 0 85,000
Issuance of common stock for debt issuance costs (in shares)             48,914          
Issuance of common stock for debt issuance costs             $ 326 249,674 0 0 0 250,000
Issuance of common stock for conversion of debt and accrued interest (in shares)             227,694          
Issuance of common stock for conversion of debt and accrued interest             $ 1,516 893,257 0 0 0 894,773
Issuance of common stock in lieu of payment of interest (in shares)             23,961          
Issuance of common stock in lieu of payment of interest             $ 160 116,443 0 0 0 116,603
Retirement of treasury shares (260,532 shares) (in shares)             (260,532)          
Retirement of treasury shares (260,532 shares)             $ (1,735) (3,359,132) 0 3,360,867 0 0
Employee and director share-based compensation             120 56,064 0 0 0 56,184
Non-controlling interest vesting of shares in subsidiary             0 (172,600) 0 0 172,600 0
Net loss             $ 0 0 (6,901,412) 0 (16,908) (6,918,320)
BALANCE (in shares) at Mar. 31, 2024             12,261,515          
BALANCE at Mar. 31, 2024             $ 81,691 362,993,642 (289,231,023) 0 155,692 74,000,002
BALANCE (in shares) at Dec. 31, 2024             23,507,577          
BALANCE at Dec. 31, 2024             $ 156,590 395,263,560 (335,651,065) 0 0 59,769,085
Common stock issuance costs             $ 0 (145,000) 0 0 0 (145,000)
Issuance of common stock for debt issuance costs (in shares)             110,059          
Issuance of common stock for debt issuance costs             $ 733 531,182 0 0 0 531,915
Issuance of common stock for conversion of debt and accrued interest (in shares)             1,490,624          
Issuance of common stock for conversion of debt and accrued interest             $ 1,798 3,999,445 0 0 0 4,001,243
Issuance of common stock in lieu of payment of interest (in shares)             35,366          
Issuance of common stock in lieu of payment of interest             $ 117 142,305 0 0 0 142,422
Net loss             $ 0 0 (9,093,931) 0 0 (9,093,931)
Adjustment for fractional shares in connection with reverse split (in shares)             246          
Issuance of common stock for lease amendment (in shares) 985,000                      
Issuance of common stock for lease amendment $ 656 $ 2,481,544 $ 0 $ 0 $ 0 $ 2,482,200            
Issuance of common stock for LINICO acquisition-related payable (in shares)             775,000          
Issuance of common stock for LINICO acquisition-related payable             $ 516 1,859,484 0 0 0 1,860,000
BALANCE (in shares) at Mar. 31, 2025             26,903,872          
BALANCE at Mar. 31, 2025             $ 160,410 $ 404,132,520 $ (344,744,996) $ 0 $ 0 $ 59,547,934